OrbiMed Advisors Israel II Ltd

CIK 1682093 · last filed 2024-10-17

OrbiMed Advisors Israel II Ltd is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for UPB, was dated Oct 17, 2024. Across all open-market trades the lifetime net is +$208.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $60.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$60.64M

Companies

3

Total Filings

5

Lifetime Open-Market Net

$208.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
UPB	Director	4,554,873	$6.10	$27.78M	$56.10M	1	2024-10-17
ACET	Director	990,254	$8.05	$7.97M	$60.00M	2	2024-01-26
LOGC	Director	3,524,997	$7.06	$24.89M	$92.04M	2	2020-10-05

Recent Filings

5 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-10-17	UPB	Mixed	+17,739,156	$56.10M	EDGAR
2024-01-26	ACET	Buy (P)	+25,000,000	$60.00M	EDGAR
2021-12-14	ACET	Grant (A)	+1,714,280	$24.00M	EDGAR
2020-10-05	LOGC	Buy (P)	+7,407,410	$44.44M	EDGAR
2018-10-25	LOGC	Mixed	+25,867,132	$47.60M	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.